Seeking to provide its pricey gene therapy to patients in countries where the drug is not yet approved, Novartis has taken the unusual step of creating a lottery. https://buff.ly/2sOWRve

From BioPortfolio: Seeking to provide its pricey gene therapy to patients in countries where the drug is not yet approved, Novartis has taken the unusual step of creating a lotter…

Read the full article here

Related Articles